MedPath

Safety evaluation of test products by PIPT

Phase 4
Completed
Registration Number
CTRI/2023/03/050887
Lead Sponsor
Dabur India Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

1.Voluntary men and women ratio of 1:1 between 18 and 65 years.

2.Having healthy skin on test area as assessed by dermatological examination.

3.For whom the investigator considers that the compliance will be correct.

4.Subjects with normal, dry, oily and combination skin

5.Subjects cooperating informed of the need and duration of the examination and ready to comply

with protocol procedures.

Exclusion Criteria

1.Pregnant/nursing mothers.

2.Scars, excessive terminal hair, or tattoo on the studied area.

3.Dermatological infection/pathology on level of studied area.

4.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Number of subjects that showed No significant irritation. <br/ ><br>2.Score of less than or equal to 2 on the Draize scale.Timepoint: Visit 1, Visit 2, Visit 3, Visit 4, Visit 5
Secondary Outcome Measures
NameTimeMethod
ATimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath